|
Delayed
Hong Kong S.E.
01:49:09 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 17.93 HKD | -1.43% |
|
+0.78% | +31.72% |
| 10-27 | Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading | MT |
| 10-26 | Zai Lab's Lung Cancer Drug Achieves Promising Response Rate in Phase 1b Trial; Shares up 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | -1.43% | +0.78% | +31.72% | -11.78% | -77.87% | 2.65B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
- Charts Zai Lab Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
